197 related articles for article (PubMed ID: 25110003)
21. PKAN pathogenesis and treatment.
Hayflick SJ; Jeong SY; Sibon OCM
Mol Genet Metab; 2022 Nov; 137(3):283-291. PubMed ID: 36240582
[TBL] [Abstract][Full Text] [Related]
22. Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration.
Rana A; Seinen E; Siudeja K; Muntendam R; Srinivasan B; van der Want JJ; Hayflick S; Reijngoud DJ; Kayser O; Sibon OC
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6988-93. PubMed ID: 20351285
[TBL] [Abstract][Full Text] [Related]
23. Pantothenate kinase-associated neurodegeneration.
Hartig MB; Prokisch H; Meitinger T; Klopstock T
Curr Drug Targets; 2012 Aug; 13(9):1182-9. PubMed ID: 22515741
[TBL] [Abstract][Full Text] [Related]
24. Knock-down of pantothenate kinase 2 severely affects the development of the nervous and vascular system in zebrafish, providing new insights into PKAN disease.
Zizioli D; Tiso N; Guglielmi A; Saraceno C; Busolin G; Giuliani R; Khatri D; Monti E; Borsani G; Argenton F; Finazzi D
Neurobiol Dis; 2016 Jan; 85():35-48. PubMed ID: 26476142
[TBL] [Abstract][Full Text] [Related]
25. Massive iron accumulation in PKAN-derived neurons and astrocytes: light on the human pathological phenotype.
Santambrogio P; Ripamonti M; Cozzi A; Raimondi M; Cavestro C; Di Meo I; Rubio A; Taverna S; Tiranti V; Levi S
Cell Death Dis; 2022 Feb; 13(2):185. PubMed ID: 35217637
[TBL] [Abstract][Full Text] [Related]
26. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name.
Hayflick SJ
Curr Opin Pediatr; 2003 Dec; 15(6):572-7. PubMed ID: 14631201
[TBL] [Abstract][Full Text] [Related]
27. Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration.
Auciello G; Di Marco A; Gonzalez Paz O; Malancona S; Harper S; Beconi M; Rossetti I; Ciammaichella A; Fezzardi P; Vecchi A; Bracacel E; Cicero D; Monteagudo E; Elbaum D
J Med Chem; 2020 Dec; 63(24):15785-15801. PubMed ID: 33320012
[TBL] [Abstract][Full Text] [Related]
28. Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model.
Brunetti D; Dusi S; Morbin M; Uggetti A; Moda F; D'Amato I; Giordano C; d'Amati G; Cozzi A; Levi S; Hayflick S; Tiranti V
Hum Mol Genet; 2012 Dec; 21(24):5294-305. PubMed ID: 22983956
[TBL] [Abstract][Full Text] [Related]
29. Skin fibroblasts from pantothenate kinase-associated neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties.
Campanella A; Privitera D; Guaraldo M; Rovelli E; Barzaghi C; Garavaglia B; Santambrogio P; Cozzi A; Levi S
Hum Mol Genet; 2012 Sep; 21(18):4049-59. PubMed ID: 22692681
[TBL] [Abstract][Full Text] [Related]
30. Bi-Allelic Mutations in Zebrafish
Mignani L; Zizioli D; Khatri D; Facchinello N; Schiavone M; De Palma G; Finazzi D
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361705
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.
Álvarez-Córdoba M; Reche-López D; Cilleros-Holgado P; Talaverón-Rey M; Villalón-García I; Povea-Cabello S; Suárez-Rivero JM; Suárez-Carrillo A; Munuera-Cabeza M; Piñero-Pérez R; Sánchez-Alcázar JA
Orphanet J Rare Dis; 2022 Aug; 17(1):311. PubMed ID: 35945593
[TBL] [Abstract][Full Text] [Related]
32. Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration.
Santambrogio P; Ripamonti M; Paolizzi C; Panteghini C; Carecchio M; Chiapparini L; Raimondi M; Rubio A; Di Meo I; Cozzi A; Taverna S; De Palma G; Tiranti V; Levi S
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456086
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration.
Johnson MA; Kuo YM; Westaway SK; Parker SM; Ching KH; Gitschier J; Hayflick SJ
Ann N Y Acad Sci; 2004 Mar; 1012():282-98. PubMed ID: 15105273
[TBL] [Abstract][Full Text] [Related]
34. Inherited Disorders of Coenzyme A Biosynthesis: Models, Mechanisms, and Treatments.
Cavestro C; Diodato D; Tiranti V; Di Meo I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983025
[TBL] [Abstract][Full Text] [Related]
35. Neurodegeneration with brain iron accumulation.
Gregory A; Hayflick SJ
Folia Neuropathol; 2005; 43(4):286-96. PubMed ID: 16416393
[TBL] [Abstract][Full Text] [Related]
36. Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene.
Yang D; Cho S; Cho SI; Kim M; Seong MW; Park SS
Orphanet J Rare Dis; 2022 Mar; 17(1):111. PubMed ID: 35246191
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Human Mutant PANK2 Proteins Affects Development and Motor Behavior of Zebrafish Embryos.
Khatri D; Zizioli D; Trivedi A; Borsani G; Monti E; Finazzi D
Neuromolecular Med; 2019 Jun; 21(2):120-131. PubMed ID: 30141000
[TBL] [Abstract][Full Text] [Related]
38. A therapeutic approach to pantothenate kinase associated neurodegeneration.
Sharma LK; Subramanian C; Yun MK; Frank MW; White SW; Rock CO; Lee RE; Jackowski S
Nat Commun; 2018 Oct; 9(1):4399. PubMed ID: 30352999
[TBL] [Abstract][Full Text] [Related]
39. Rational Design of Novel Therapies for Pantothenate Kinase-Associated Neurodegeneration.
Thakur N; Klopstock T; Jackowski S; Kuscer E; Tricta F; Videnovic A; Jinnah HA
Mov Disord; 2021 Sep; 36(9):2005-2016. PubMed ID: 34002881
[TBL] [Abstract][Full Text] [Related]
40. Proton magnetic resonance spectroscopy detects cerebral metabolic derangement in a mouse model of brain coenzyme a deficiency.
Li Y; Steinberg J; Coleman Z; Wang S; Subramanian C; Li Y; Patay Z; Akers W; Rock CO; Jackowski S; Bagga P
J Transl Med; 2022 Feb; 20(1):103. PubMed ID: 35197056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
